Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (447)

Latest Posts

About This Stock More About This Stock
7 Monster Stock Market Predictions For The Week Of December 9th
Article By: Michael J. Kramer
Sunday, December 8, 2019 4:38 PM EST
Stocks will try to pick up where they left off on Monday, following the strong jobs report. This week will feature CPI, PPI, the Fed, and the ECB. With that, the S&P 500 will try to advance to 3,200 its next level of significant resistance.
In this article: ILMN, REGN, GILD, NFLX, SWKS, TSLA
Read
Stocks Are Pointing To More Gains For November 27
Article By: Michael J. Kramer
Wednesday, November 27, 2019 9:17 AM EST
Markets are pointing to a higher opening once again.
In this article: FCX, ACAD, ILMN, GILD, SPX, JD
Read
Stocks Are Mixed Overseas, But Will Try To Push Higher In The US
Article By: Michael J. Kramer
Tuesday, November 26, 2019 9:31 AM EST
Stocks are pointing to a slightly lower opening here in the US after a record-setting day on November 25.
In this article: SPY, SQ, DIS, ACAD, MU, NFLX, GILD
Read
November 2019 Stock Considerations
Article By: Keith Park
Saturday, November 2, 2019 3:45 PM EST
We have witnessed some pretty harsh declines this year only to be followed by strong rebounds that keeps us flirting with new all-time highs. The lesson would be to stay in the game, stay diversified, keep collecting those dividends.
In this article: MCD, MO, GILD
Read
Gilead Earnings, Revenue In Line
Video By: CNBC
Thursday, October 24, 2019 5:47 PM EST
Gilead Sciences reports earnings.
In this video: GILD
Watch

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments